Skip to main content
Clinical Trials/NCT03703986
NCT03703986
Unknown
N/A

Explore the Causes and Predictors of Early Neurological Deterioration Occurred in Patients With Acute Ischemic Stroke

The First Affiliated Hospital with Nanjing Medical University1 site in 1 country1,200 target enrollmentNovember 20, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cerebral Infarction
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Enrollment
1200
Locations
1
Primary Endpoint
National Institutes of Health Stroke Scale
Last Updated
7 years ago

Overview

Brief Summary

This study set out to explore the risk factors of early neurological deterioration (END) occurred in patients with acute ischemic stroke and to investigate the corresponding predictors.

Detailed Description

END refers to the illness aggravation occurred in the early stage of stroke and often indicates a poor outcome. Some clinical scales may play an important role in its diagnoses and treatments. Across the reviewed studies, the risk factors of END, which included biochemical parameters, neuroimaging, ect. were explored incompletely and the effective predictors of END is unknown. We aimed to explore the risk factors of END and investigate the predictive value of certain scales.

Registry
clinicaltrials.gov
Start Date
November 20, 2018
End Date
January 30, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Subjects with acute ischemic stroke
  • Subjects with detailed progress notes

Exclusion Criteria

  • Subjects with thrombolysis therapy
  • Subjects with transient ischemia attach
  • Subjects complicated with seriously underlying diseases

Outcomes

Primary Outcomes

National Institutes of Health Stroke Scale

Time Frame: 7 days

National Institutes of Health Stroke Scale (NIHSS) can assess the severity of stroke. The total score of NIHSS ranges from 0 to 42, with higher scores indicating better neurological function.

Canadian Neurological Scale

Time Frame: 7 days

Canadian Neurological Scale (CNS) can assess the severity of stroke as well. The total score of CNS ranges from 0 to 10, with higher scores indicating worse neurological function.

Secondary Outcomes

  • Neuroimaging data(7days)
  • Blood parameters(7days)

Study Sites (1)

Loading locations...

Similar Trials